Assembly Biosciences, Inc. (ASMB)
34.07
-0.73
(-2.10%)
USD |
NASDAQ |
Aug 28, 16:00
34.00
-0.07
(-0.21%)
After-Hours: 20:00
Assembly Biosciences Total Liabilities (Quarterly) : 25.18M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 25.18M |
| March 31, 2026 | 36.90M |
| December 31, 2025 | 51.54M |
| September 30, 2025 | 57.30M |
| June 30, 2025 | 62.68M |
| March 31, 2025 | 71.88M |
| December 31, 2024 | 86.62M |
| September 30, 2024 | 74.26M |
| June 30, 2024 | 80.64M |
| March 31, 2024 | 87.28M |
| December 31, 2023 | 96.37M |
| September 30, 2023 | 9.915M |
| June 30, 2023 | 11.63M |
| March 31, 2023 | 12.78M |
| December 31, 2022 | 19.94M |
| September 30, 2022 | 19.11M |
| June 30, 2022 | 19.47M |
| March 31, 2022 | 15.94M |
| December 31, 2021 | 23.68M |
| September 30, 2021 | 24.33M |
| June 30, 2021 | 30.34M |
| March 31, 2021 | 31.66M |
| December 31, 2020 | 49.93M |
| September 30, 2020 | 35.76M |
| June 30, 2020 | 27.69M |
| Date | Value |
|---|---|
| March 31, 2020 | 61.54M |
| December 31, 2019 | 74.67M |
| September 30, 2019 | 66.86M |
| June 30, 2019 | 66.80M |
| March 31, 2019 | 68.85M |
| December 31, 2018 | 57.39M |
| September 30, 2018 | 53.54M |
| June 30, 2018 | 53.32M |
| March 31, 2018 | 53.64M |
| December 31, 2017 | 56.18M |
| September 30, 2017 | 65.18M |
| June 30, 2017 | 66.24M |
| March 31, 2017 | 66.40M |
| December 31, 2016 | 18.24M |
| September 30, 2016 | 19.08M |
| June 30, 2016 | 16.64M |
| March 31, 2016 | 15.17M |
| December 31, 2015 | 15.00M |
| September 30, 2015 | 14.25M |
| June 30, 2015 | 13.84M |
| March 31, 2015 | 13.73M |
| December 31, 2014 | 12.65M |
| September 30, 2014 | 13.19M |
| June 30, 2014 | 1.470M |
| March 31, 2014 | 1.462M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 37.62B |
| BridgeBio Pharma, Inc. | 3.723B |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 330.83M |
| Shareholders Equity (Quarterly) | 305.65M |
| Debt to Equity Ratio | 0.0077 |
| Current Ratio | 13.99 |
| Net Debt Paydown Yield | 0.02% |